Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Baxter
Dow
Cerilliant
Healthtrust
Farmers Insurance
Deloitte
Boehringer Ingelheim
Teva

Generated: October 20, 2017

DrugPatentWatch Database Preview

Fougera Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA, and when can generic versions of FOUGERA drugs launch?

FOUGERA has one hundred and nineteen approved drugs.

There is one US patent protecting FOUGERA drugs.

There are seventeen patent family members on FOUGERA drugs in fifteen countries and twenty-three supplementary protection certificates in ten countries.

Summary for Applicant: Fougera

International Patents:17
US Patents:1
Tradenames:56
Ingredients:48
NDAs:119
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL088167-001Dec 16, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
HYDROCORTISONE
hydrocortisone
CREAM;TOPICAL089414-001Dec 16, 1986ATRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
TACROLIMUS
tacrolimus
OINTMENT;TOPICAL200744-001Sep 9, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
TERCONAZOLE
terconazole
SUPPOSITORY;VAGINAL076850-001Jul 12, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL085692-002Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms
MUPIROCIN
mupirocin
OINTMENT;TOPICAL065192-001Nov 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL088169-001Dec 16, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
OINTMENT;TOPICAL019141-001Sep 4, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Fougera Pharms
ERYTHROMYCIN
erythromycin
SOLUTION;TOPICAL064187-001Sep 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera Pharms
CUTIVATE
fluticasone propionate
CREAM;TOPICAL019958-001Dec 18, 1990► Subscribe► Subscribe
Fougera Pharms
ACLOVATE
alclometasone dipropionate
OINTMENT;TOPICAL018702-001Dec 14, 1982► Subscribe► Subscribe
Fougera Pharms
ACLOVATE
alclometasone dipropionate
CREAM;TOPICAL018707-001Dec 14, 1982► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
SOLUTION;TOPICAL019966-001Feb 22, 1990► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
CREAM;TOPICAL019322-001Dec 27, 1985► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera Pharms
CUTIVATE
fluticasone propionate
OINTMENT;TOPICAL019957-001Dec 14, 1990► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FOUGERA drugs

Drugname Dosage Strength Tradename Submissiondate
diclofenac sodium
Topical Gel3%
SOLARAZE
12/16/2009
fluticasone propionate
Lotion0.05%
CUTIVATE
7/28/2008

International Patent Family for Fougera Drugs

Country Document Number Estimated Expiration
Australia754480► Subscribe
China1326350► Subscribe
Hungary0104251► Subscribe
Czech Republic20011419► Subscribe
Poland348029► Subscribe
European Patent Office1123101► Subscribe
World Intellectual Property Organization (WIPO)0024401► Subscribe
Brazil9914703► Subscribe
Turkey200101109► Subscribe
Japan2002528418► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Fougera Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
C/GB10/005United Kingdom► SubscribePRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
269Luxembourg► SubscribePRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C/GB02/033United Kingdom► SubscribePRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
C0013Belgium► SubscribePRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
90041Netherlands► SubscribePRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
C0067France► SubscribePRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Merck
Argus Health
Cantor Fitzgerald
Fish and Richardson
Novartis
McKesson
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot